Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,921 | -14,826 | -26,294 | -16,364 | -9,721 |
| Depreciation Amortization | 132 | 64 | 140 | 90 | 49 |
| Other Working Capital | -2,966 | 1,863 | -481 | 535 | 21 |
| Other Operating Activity | 6,662 | 3,974 | 2,890 | 1,022 | 512 |
| Operating Cash Flow | $-26,093 | $-8,925 | $-23,745 | $-14,717 | $-9,139 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -490 | -239 | -645 | -540 | -300 |
| Investing Cash Flow | $-490 | $-239 | $-645 | $-540 | $-300 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -9 | -9 | -9 |
| Common Stock Issued | 265 | 238 | 181,734 | 513 | 536 |
| Other Financing Activity | 0 | 0 | 129,623 | 312,352 | 128,892 |
| Financing Cash Flow | $265 | $238 | $311,348 | $312,856 | $129,419 |
| Beginning Cash Position | 302,425 | 302,425 | 15,467 | 15,467 | 15,467 |
| End Cash Position | 276,107 | 293,499 | 302,425 | 313,066 | 135,447 |
| Net Cash Flow | $-26,318 | $-8,926 | $286,958 | $297,599 | $119,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,093 | -8,925 | -23,745 | -14,717 | -9,139 |
| Capital Expenditure | -490 | -239 | -661 | -556 | -300 |
| Free Cash Flow | -26,583 | -9,164 | -24,406 | -15,273 | -9,439 |